In a complaint filed yesterday in the Southern District of California, Pfizer alleges that Chun Xiao (Sherry) Li, a “soon-to-be former employee,” uploaded 12,000 files from her Pfizer-issued computer to Google Drive and back down to her own personal devices and left with the information.
Pfizer’s complaint begins: “Conventional wisdom says that the cover up is worse than the crime. Pfizer is not yet sure whether that is the case here…” That’s a rather interesting way for a company with $41.9 Billion in revenue in 2020 to begin a complaint against a single employee who left with some files, don’t you think? Who is covering up what?
Pfizer: “Due to the sheer number of documents Ms. Li misappropriated, Pfizer has yet to understand the full scope of trade-secret and confidential information in her possession. While Ms. Li possesses thousands of documents potentially related to numerous Pfizer vaccines, drugs, and other innovations, this Complaint focuses on Pfizer’s COVID-19 vaccine and its avelumab and elranatamab monoclonal antibodies.” The statement “yet to understand the full scope” seems to haven been included by Pfizer to disavow knowledge of risks. Pfizer goes on to explain that they had a “moral and scientific imperative to bring to the public a vaccine as soon as possible.” That language can be construed as an excuse for any liabilities that Pfizer now knows to exist with their vaccine. I don’t see why else they would include the language in the complaint otherwise.
Scientists have recently expressed concerns about long-term cancer risks associated with the Pfizer/BioNtech’s COVID-19 vaccine. Pfizer is active in cancer research. Avelumab and elranatamab are both anti-cancer drugs produced by Pfizer. BioNtech, Pfizer’s partner in the COVID-19 vaccines, announced on Oct 1, 2020 that it had begun trials of an mRNA-based cancer vaccine.
Dr. Mikolaj Rasjek: “Now BRCA1, if you mutate that gene, it’s one of the highest pre-dispositional mutations for cancer that you can have.”
Pfizer’s said they believed Li took her 12,000 files to “a competitor believed to be Xencor, Inc.” Xencor’s website says: “Xencor is expanding the therapeutic boundaries of monoclonal antibody and cytokine drugs. Powered by its XmAb® protein engineering platform, Xencor is developing a broad pipeline of drug candidates that are optimized to treat patients with cancer and autoimmune disorders. 22 programs are in clinical testing, and many more are in preclinical development.”
Pfizer said that Ms. Li was hired by Pfizer in 2006 as Associate Director of Statistics in Pfizer’s Global Product Development Group in China. She transferred to La Jolla, California in 2016 and continued in the same role.
According to Pfizer: “The scientists based in La Jolla focus on two areas of research and development: discovering and developing new medicines to treat many forms of cancer; and, discovering novel prophylactic and therapeutic vaccines for the prevention and treatment of significant human maladies (in the areas of cancer and central nervous system diseases).” It is not known to me if avelumab and elranatamab were developed at La Jolla. Here’s some brief information on these two drugs.
The European Medicines Agency described the action of Avelumab as follows: “Avelumab is a monoclonal antibody, a protein designed to attach to PD-L1. PD-L1 is a protein produced by several cancers and it prevents the activation of T cells, which are part of the body’s immune (defence) system. By attaching to PD-L1, avelumab stops the action of PD-L1 and so allows activation of T cells to attack cancer cells.”
The European Medicines Agency granted an “orphan designation” for Avelumab to treat gastric cancer in December 2016. Avelumab was granted FDA approval for metastatic Merkel cell carcinoma in March, 2017.
Pfizer’s description of the method of action of elranatamab: “Elranatamab is a bispecific antibody designed to bind to BCMA which is highly expressed on the surface of multiple myeloma cells, and the CD3 receptor found on the surface of cancer-fighting T-cells, bridging them together to activate an immune response. Binding affinity to BCMA and CD3 has been optimized, to potentially elicit more potent T-cell-mediated anti-myeloma activity.”
Robert Kennedy spoke on the topic of knowledge, liability and the pharmaceutical industry on Nov 22, 2021:
(2:11) “…the four companies that make all the childhood vaccines are all of them serial convicted criminals. And this is Sanofi, Glaxo, Merck, and Pfizer. Since 2009, those 4 companies have paid over 35 billion dollars in criminal penalties, in damages, in civil penalties for falsifying science, for defrauding regulators, for lying to the public, for killing hundreds of thousands of people unnecessarily.”
(4:03). “…we have government conspiring with those same companies to hid facts about these mandatory vaccines from the public. And remember, these are vaccines that have zero liability. They’ve passed acts- the Prep Act in the United States, and also the Cares Act, that give these companies immunity so that no matter how now negligent they are, no matter how reckless they are, no matter how grievous your injury, no matter how toxic their ingredients, you can’t sue them. Not only that, the only way that you can sue these companies, if you can show that they knew their product caused the particular harm that you suffered, and that they didn’t tell people about it.”
(4:58). “So the incentive for these companies is to know as little bit about the product as possible. Because the less they know, the less liability they have, so they create these pre-clinical trials, that are fraudulent trials, that are designed to hide- not just from the public and from regulators, but also from the company about whether or not there’s any problem.”
(5:21). “And because of that we’re seeing not just products that are very, very, poorly tested, and that they’re being mandated to the public. We’re being ordered to take a product and required to take a product in order to be able to exercise our other rights- to transportation, to education, to leaving our homes in some cases, and that really is the essence of Tyranny.”
As Robert Kennedy discussed, the pharmaceutical industry uses “fraudulent trials” designed to hide side effects of their products. There’s a huge problem for Pfizer with the files that Sherry Li took that may expose these problems, if they exist. She took Pfizer’s “E2E Clinical Development & Submissions Playbook” on their COVID-19 vaccine that they developed with BioNTech.
What’s E2E? “Efficacy to Effectiveness (E2E) is an approach to clinical trial design that addresses the effectiveness and safety gaps that often occur in standard randomized controlled trials.” So this is the data that Pfizer would have that the FDA did not have on “effectiveness and safety gaps.” This could prove that Pfizer knew about risks of their vaccines. This could expose the methods coordinated between Pharma and the FDA to conceal those risks from the public.
The FDA has not been forthcoming about producing Pfizer’s documents used to prove the safety and effectiveness for their COVID-19 vaccine. (A lawsuit was filed last week to force the FDA to release more than 500 pages per month related to Pfizer’s data used to substantiate the safety and effectiveness of their COVID-19 vaccine to the FDA).
If cancer and other risks of the Pfizer/BioNTech COVID-19 vaccine is determined in the future, people will ask “who knew what and when” at Pfizer. They will also ask the same question of Xencor and Sherry Li. Hopefully Li et al will become “whistleblowers” if they suspect wrongdoing.
Make a one-time donation
Make a monthly donation
Make a yearly donation
Choose an amount
Or enter a custom amount
Please contribute to my research and reporting.
Your contribution is appreciated.
Your contribution is appreciated.DonateDonate monthlyDonate yearly